Pimecrolimus is a medicine used to treat mild to moderate eczema (atopic dermatitis). It's a cream you rub onto the affected skin. It works by calming the immune cells in the skin that cause redness and itching.
Every report comes from a Lived member, sent anonymously.
Have you tried Elidel (Pimecrolimus) for Eczema?
Pimecrolimus, sold as Elidel and as generic pimecrolimus cream 1%, is a prescription cream for mild to moderate atopic dermatitis, the most common form of eczema. It is approved for adults and children 2 years and older whose immune systems are working normally. It is not approved for children under 2. It belongs to a group of medicines called topical calcineurin inhibitors, which calm skin inflammation without being a steroid. On the US label it is a second-line treatment: it is meant for people whose eczema has not improved enough with other prescription creams, such as topical steroids, or for whom those creams are not a good choice. A key reason to use it is sensitive skin such as the face, because it does not thin the skin the way steroid creams can with repeated use. It is used in short courses or on and off as flares come and go, not applied every day indefinitely.
Eczema involves an overactive immune response in the skin. Immune cells called T cells release chemical signals that drive the redness, swelling and itch. Pimecrolimus blocks calcineurin, an enzyme these cells need in order to switch on, so they produce fewer of those inflammatory signals. It also reduces the release of irritating chemicals from mast cells, another type of immune cell in the skin. Because it acts on the immune response rather than on the structure of the skin, it does not cause the skin thinning linked to long-term steroid use. Only small amounts reach the bloodstream when it is applied to the skin. The label notes that exactly how these effects lead to clearer eczema is not fully understood.
Pimecrolimus comes as a 1% cream. A thin layer is applied to the affected skin twice a day, only on areas with eczema, using the smallest amount that controls the symptoms. Wash your hands first, and if applying after a bath or shower, make sure the skin is dry. Moisturizers can still be used and go on after the pimecrolimus. Treated skin can be covered with normal clothing but should not be wrapped in bandages, dressings or wraps, which may increase how much medicine the body absorbs. Avoid bathing, showering or swimming right after applying it, since that washes the cream off. Keep it out of the eyes, nose, mouth, vagina and rectum; if it gets there, wipe it off and rinse with cold water. Use stops once the itch, rash and redness clear. If the eczema comes back, the prescriber can explain when and how to restart.
Burning, stinging, warmth or itching where the cream is applied are the most common side effects. In clinical trials, burning affected between about 8% and 26% of people. It is usually worst in the first few days and fades as the eczema heals; burning that lasts more than a week is worth reporting to the prescriber. Headache, cold-like symptoms, cough and fever were also reported more often than with an inactive cream, particularly in children. Some people notice their face flushing red after drinking alcohol. Because the cream dampens immune defenses in the skin, infections need attention. Cold sores, chickenpox or shingles, or a painful, spreading rash of blisters on eczema-affected skin (which can be eczema herpeticum, a herpes infection that spreads across eczema) should prompt a call to the prescriber right away. So should oozing, crusting or other signs of a bacterial skin infection, or swollen glands in the neck. Warts can also appear or worsen. Swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, can signal a serious allergic reaction and needs emergency care.
Pimecrolimus carries a boxed warning from the US Food and Drug Administration (FDA), the agency's most prominent kind of warning, because its long-term safety has not been established. Rare cases of skin cancer and lymphoma (a cancer of the immune system) have been reported in people using topical calcineurin inhibitors, although a cause-and-effect link has not been shown. The concern comes mainly from animal studies and from transplant patients who take related medicines internally for long periods to suppress the immune system. A large 2022 analysis of studies covering more than 3 million people with eczema, followed for about a year on average, found no increase in cancer risk with these creams. The label still says to avoid continuous long-term use, to apply it only to skin with eczema and not to use it in children under 2. It should not be used by people whose immune systems are weakened, including those taking medicines that suppress the immune system, such as after an organ transplant. It is also not used on skin that may be cancerous or precancerous; some skin lymphomas can look like eczema. Any skin infection at the treatment site should be cleared up before starting. During treatment, limit time in the sun even when the cream is not on the skin, and avoid tanning beds, sun lamps and ultraviolet light therapy. Loose clothing that covers treated skin helps outdoors. Interactions with other medicines are unlikely because so little reaches the bloodstream. Caution is still advised for people with widespread or severely inflamed eczema who also take medicines that slow its breakdown in the body, such as the antifungals itraconazole, ketoconazole and fluconazole, or the antibiotic erythromycin. There are no good studies in pregnancy, and it is not known whether pimecrolimus passes into breast milk, so anyone pregnant, planning a pregnancy or breastfeeding should discuss it with the prescriber.
Pimecrolimus is used during flares and stopped once the skin clears. Burning in the first few days is common and usually settles as the skin heals. If the eczema has not improved after 6 weeks, the prescriber should re-examine the skin and confirm the diagnosis, since other skin conditions can look like eczema. In studies, it worked about as well as mild or medium-strength steroid creams, and it cleared or nearly cleared eczema in children more often than an inactive cream. It is not approved for severe eczema, which usually needs other treatment. Eczema tends to return, so repeated courses with breaks in between are common. Its safety has been studied for up to 1 year of on-and-off use. Regular moisturizing and gentle skin care remain the foundation of eczema treatment alongside it.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Elidel (Pimecrolimus), what you've noticed, or ask the community a question.